MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-15-0011231
Glynis Pharmaceutical Private Limited - chemicals and materials in Ranaghat, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2021
₹1.95 Cr
▲ 264% YoY
Net profit · FY 2021
₹2.16 Lakh
Net margin 1.1%
EBITDA · FY 2021
₹3.07 Lakh
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Open charges
₹6.5 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
4
Provident fund records
About Glynis Pharmaceutical Private Limited
Data last updated:
Glynis Pharmaceutical Private Limited is a private limited company based in Ranaghat, West Bengal, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 09 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2014PTC204567. Its GSTIN is 19AAFCG8392K1ZW (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Supriya Santra and Sudip Kumar Mondal.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 155 No. Ranaghat Mouza Swami Vivekananda Sarani P.O. & P.S. Ranaghat, West Bengal, India – 741201.
As per the financials filed for FY 2021, the company reported a revenue of ₹1.95 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.16 Lakh (net margin 1.1%) and EBITDA of ₹3.07 Lakh (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 547% over three years and 120% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹6.5 Lakh on record. Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Glynis Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-15-0011231). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glynispharmaceuticals.com.
Company details
CIN U24100WB2014PTC204567
Registration Number 204567
Incorporation Date 09 December 2014
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-15-0011231
Recognitions & Rankings of Glynis Pharmaceutical
Contact details
Glynis Pharmaceutical Private Limited's registered office is in Ranaghat, West Bengal. Its website is glynispharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address155 No. Ranaghat Mouza Swami Vivekananda Sarani P.O. & P.S. Ranaghat, West Bengal, India – 741201
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Glynis Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Glynis Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Glynis Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Glynis Pharmaceutical Private Limited, buy the company report.
Financials of Glynis Pharmaceutical Private Limited
FY 2021 filings availableGlynis Pharmaceutical Private Limited reported revenue of ₹1.95 Cr (up 264% YoY) for FY 2021.
Revenue · FY 2021
₹1.95 Cr ▲ 264%
Net profit · FY 2021
₹2.16 Lakh margin 1.1%
EBITDA · FY 2021
₹3.07 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 264%
3 years · compounded
▲ 547%
5 years · compounded
▲ 120%
EBITDA CAGR growth
1 year
▲ 89%
3 years · compounded
▲ 75%
5 years · compounded
▲ 21%
Revenue has grown at a compounded annual rate (CAGR) of 120% over five years, including 264% growth in the latest year. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.95 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glynis Pharmaceutical Private Limited, buy the company report.
Board of directors of Glynis Pharmaceutical Private Limited
Glynis Pharmaceutical has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Supriya Santra Also directs: Glynis Medicare Private Limited, Scute Healthcare Private Limited | Director | 08 Feb 2021 | 5 Years 8 Months | Current |
| Sudip Kumar Mondal | Director | 23 Jul 2019 | 7 Years 3 Months | Current |
| Moumita Das Mondal Also directs: Glynis Medicare Private Limited | Director | 25 Jan 2022 | 4 Years 9 Months | Current |
| Shakyasen Chakraborty | Director | 09 Dec 2014 | 11 Years 10 Months | Current |
| Tapan Bera Also directs: Glynis Medicare Private Limited | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
| Santu Kumar Mondal Also directs: Glynis Lifecare Private Limited | Director | 07 Jan 2019 | 7 Years 9 Months | Current |
Auditor
Glynis Pharmaceutical Private Limited is audited by KUMARROY BARMAN PRASANTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMARROY BARMAN PRASANTA & ASSOCIATES | FY 2021 | 330634E |
Shareholding
The shareholding of Glynis Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Glynis Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Jan 2016 | 10614985 | Vijaya Bank | ₹6.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Glynis Pharmaceutical Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Ltd. | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed against the company by M/S Ryze Lifecare | Pending |
| District court, East, Delhi | Civil suit | Filed against the company by an individual | Disposed |
To see the full case history of Glynis Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Glynis Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Glynis Pharmaceutical Private Limited has a workforce of 4 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
4
Active EPFO establishments
1
Employee growth
-83.33%
GST
Glynis Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAFCG8392K1ZW | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Glynis Pharmaceutical Private Limited, buy the company report.
Recent activity
Glynis Pharmaceutical Private Limited has 8 board changes on record since 2014: 6 appointments and 2 cessations. The latest: Basanti Majumder ceased to be Director on 01 Jun 2022.
Ceased
Basanti Majumder ceased to be Director.
Appointed
Moumita Das Mondal was appointed as Director.
AGM
Glynis Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Filing
Glynis Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Kolkata.
Appointed
Supriya Santra was appointed as Director.
Appointed
Sudip Kumar Mondal was appointed as Director.
Ceased
Anirban Chakraborty ceased to be Director.
Appointed
Santu Kumar Mondal was appointed as Director.
Appointed
Tapan Bera was appointed as Director.
Charges
A charge with Vijaya Bank amounted to Rs. 6.50 Lakh with Charge ID 10614985 was registered on 18 Jan 2016.
Appointed
Shakyasen Chakraborty was appointed as Director.
Incorporation
09 Dec 2014
Glynis Pharmaceutical Private Limited was registered on 09 Dec 2014 with Roc Kolkata & aged 11 years 10 months as per MCA records.
Frequently asked questions
Glynis Pharmaceutical is an active private limited company based in Ranaghat, West Bengal, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 09 December 2014 (12+ years old) and is registered under CIN U24100WB2014PTC204567.
Glynis Pharmaceutical has 6 current directors:
- Supriya Santra - Director
- Sudip Kumar Mondal - Director
- Moumita Das Mondal - Director
- Shakyasen Chakraborty - Director
- Tapan Bera - Director
- Santu Kumar Mondal - Director
The latest financial statements of Glynis Pharmaceutical on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Glynis Pharmaceutical is 19AAFCG8392K1ZW, registered in West Bengal.
The CIN (Corporate Identification Number) of Glynis Pharmaceutical is U24100WB2014PTC204567. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glynis Pharmaceutical has 3 court cases on record: 3 filed against it. 2 are pending.
Glynis Pharmaceutical was incorporated on 09 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
Basanti Majumder ceased to be Director on 01 Jun 2022. Moumita Das Mondal was appointed as Director on 25 Jan 2022. Supriya Santra was appointed as Director on 08 Feb 2021. Glynis Pharmaceutical has 8 board changes on record in total.
Yes, Glynis Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-15-0011231).
Glynis Pharmaceutical can be reached through the website glynispharmaceuticals.com. Its registered office is in Ranaghat, West Bengal, India.